Assessing epidemiology of cutaneous leishmaniasis in Isfahan, Iran

Journal of Vector Borne Diseases

Volumn 50, Issue 1, 2013, Pages 30-37

  Karami, Marziyeh ^a   Doudi, Monir ^a   Setorki, Mahbubeh ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Cutaneous leishmaniasis; Epidemiology; Iran

Indexed keywords

MEGLUMINE ANTIMONATE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANALYTICAL RESEARCH; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OCCUPATION; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEASONAL VARIATION; SEX DIFFERENCE; SKIN LEISHMANIASIS; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; IRAN; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84877250590     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bailey MS, Lockwood DNJ. Cutaneous leishmaniasis. Clinics Dermatol 2007; 25: 203-11.
2. Blum JA, Hots CF. Treatment of cutaneous leishmaniasis in travelers. J Travel Med 2009; 16: 123-31.
3. Postigo JA. Leishmaniasis in the World Health Organization Eastern Mediterrranean Region. Int J Antimicrob Agents 2010; 36 (Suppl): S62-5.
4. Nadim A, Rashti AS, Faghih A. Epidemiology of cutaneous leishmaniasis in Iran: B-Khorassom. 3-Human infection. Bull Soc Pathol Exot Filiales 1969; 62: 702-10.
5. Klaus SN, Frankenberg S, Ingber A. Epidemiology of cutaneous leishmaniasis. Clinics Dermatol 1999; 17: 257-60.
6. Razmjue S, Hejazy SH, Motazedian MH. A new focus of zoonotic cutaneous leishmaniasis in Shiraz, Iran. Trans R Soc Trop Med Hyg 2009; 103: 727-30.
7. Aflatoonian MR, Sharifi I. Frequency of cutaneous leishmaniasis among patients referred to the health center for disease control in Bam district in 1999-2003. J Rafsanjan Univ Med Sci 2006, 2: 123-8.
8. Doudi M, Ghasemi F, Setorki M. Genetic polymorphism analysis of Leishmania tropica isolated from three endemic regions (Bam, Kermanshah and Mashhad) in Iran by PCR-RFLP technique and based on ITS1 sequences. African J Microbiol Res 2012; 12: 2970-5.
9. Pourmohammadi B, Motazedian MH, Kalantari M. Rodent infection with Leishmania in a new focus of human cutaneous leishmaniasis, in northern Iran. Ann Trop Med Parasitol 2008: 2: 127-33.
10. Doudi M, Hejazi SH, Razavi MR, Narimani M, Khanjani S, Eslami G. Comparative molecular epidemiology of Leishmania major and Leishmania tropica by PCR-RFLP technique in hyperendemic cities of Isfahan and Bam, Iran. Med Sci Monit 2010; 11: 530-5.
11. Sharifi I, Zamani F, Aflatoonian MR, Fekri A. Reported an epidemic of cutaneous leishmaniasis, and factors that many cause the city of Bam in Kerman province. Iranian J Epidemiol 2008; 1: 53-8.
12. Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F. Leishmaniasis vaccine candidates for development: A global overview. Indian J Med Res 2006; 3: 423-38.
13. Nadim A, Faghih MA. The epidemiology of CL in Isfahan Provience of Iran. Trans R Soc Trop Med Hyg 1968; 62: 534-43.
14. Kishore K, Kumar V, Kesari S, Dinesh DS, Kumar AJ, Das P, et al. Vector control in leishmaniasis. Indian J Med Res 2006; 3: 467-72.
15. Control of Leishmaniasis. WHO Tech Rep Ser 2009; 793: 158.
16. Minodier P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis 2007; 5: 150-8.
17. Momeni AZ, Aminjavaheri M. Clinical picture of cutaneous leishmaniasis in Isfahan, Iran. Int J Dermatol 1994; 4: 260-5.
18. Moemenbellah-Fard MD, Kalantari M, Rassi Y, Javadian E. The PCR-based detection of Leishmania major infections in Meriones libycus from Southern Iran. Ann Trop Med Parasitol 2003; 8: 811-6.
19. Gramiccia M, Gradoni L. The current status of zoonotic leishmaniasis and approaches to disease control. Int J Parasitol 2005; 35(11-12): 1169-80.
20. Khoury S, Kubeyinje K. Epidemiology of cutaneous leishmaniasis (CL) in Jordan: 1983-92. Int J Dermatol 1996; 8: 566-9.
21. Rafati N, Shapori-Moghadam A, Ghorbani R. Epidemiological survey of cutaneous leishmaniasis in Damghan (1999-2005). Persian J Semnan Univ Med Sci 2004; 1: 247-53.
22. Birjees MK. Epidemiology of cutaneous leishmaniasis in Larkana district of Sindh province with particular reference to phlebotomine sandflies. Islamabad, Pakistan: Public Health Division, National Institute of Health (SGS) 2001 No. 67. Available from: http:// www.emro. WHO Int/ TDR/ PDF/ Proj 01-67. Pdf.
23. Berman JD. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24: 684-703.
24. Klaus SN, Frankenberg S, Ingber A. Epidemiology of cutaneous leishmaniasis. Clin Dermatol 1999; 17: 257-60.
25. Pourmohammadi B, Motazedian MH, Kalantari M. Rodent infection with Leishmania in a new focus of human cutaneous leishmaniasis, in northern Iran. Ann Trop Med Parasitol 2008; 2: 127-33.
26. Rassi Y, Javadian E, Jalahi M, Motazedian MH, Vatandoost H. Investigation on zoonotic cutaneous leishmaniasis, Southern Iran. Iranian J Public Health 2004; 1: 31-5.
27. Zahirnia AH, Moradi AR, Nourozi NA, Bathaie SJN, Erfani A, Moradi A. Epidemiology of cutaneous leishmaniasis in the province during the years 2002 to 2007. J North Khorasan Univ Med Sci 2011; 3(4): 15-23.
28. Sharifi I, Fekri AR, Aflatoonian MR, Nadim M, Nikiany, Kamesipour A. Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam 1994-95. Bull World Health Organ 1998; 3: 289-93.
29. Abbasi A, Ghanbary MR, Kazem Nejad K. The epidemiology of cutaneous leishmaniasis in Gorgan 1998-2001. Sci J Army Univ Med Sci 2004; 4: 175-9.
30. Hamzavi Y, Frozani A, Moheb Ali M. Cutaneous leishmaniasis in Bosheher Province 1984-1998. Sci J Kermanshah Uni Med Sci 2001; 3: 1-7.
31. Al-Gindan Y, Abdul-Aziz O, Kubba R. Cutaneous leishmaniasis in AL-Hassa, Saudi Arabia. Int J Dermatol 1984; 23: 194-7.
32. Mujtaba G, Khalid M. Cutaneous leishmaniasis in Multan. Pakistan Int J Dermatol 1998; 11: 843-5.
33. El-on J, Sneier R, Ervin E. Leishmania major: Bacterial contamination of cutaneous lesion in experimental animals. Isr J Med Sci 1992; 12: 847-51.
34. Doroodgar A, Mahbobi S, Nemetian M, Say Yah M, Doroodgar M. An epidemiological study of cutaneous leishmaniasis in Kashan (2007-2008). J Semnan Univ Med Sci 2009; 3: 177-84.
35. Berman JD. Recommendation for treating leishmaniasis with glucantime. Am J Trop Med Hyg 1992; 46: 296-306.
36. Meyerhoff AUS. U.S. Food and drug administration approval of AmBisome (liposomal amphotericine B) for treatment of visceral leishmaniasis. Clin Infect Dis 1999; 28: 49-51.
37. Shahian M, Alborzi A. Effect of meglumine antimoniant on the pancreas during treatment of visceral leishmaniasis in children. Med Sci Monit 2009; 15(6): 290-3.
38. Marj J. Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. J Lab Clin Med 1991; 118: 111-9.
39. Sato J, Buffer P, Grogl M, Berman J. Successful treatment of Colombian cutaneous leishmaniasis with four infections of pentamidine. Am J Trop Med Hyg 1994; 50: 107-11.